Basel, Switzerland

Christor Hildenbrand

This inventor holds 1 USPTO granted patent. Top assignee: Ciba-Geigy Corporation. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christor Hildenbrand. Retrieved from https://idiyas.com/inventor/christor-hildenbrand

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christor Hildenbrand: Innovator in Anthelmintics

Introduction

Christor Hildenbrand is a notable inventor based in Basle, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anthelmintic compounds. His work has implications for treating parasitic infections, which are a major health concern worldwide.

Latest Patents

Hildenbrand holds a patent for anthelmintically active compounds, specifically described by the formula I. The compounds include various functional groups such as hydrogen, halogen, and alkyl chains, which enhance their effectiveness against parasites. This patent represents a crucial advancement in the search for effective treatments.

Career Highlights

Throughout his career, Hildenbrand has been associated with Ciba-Geigy Corporation, a prominent player in the pharmaceutical industry. His work has contributed to the company's reputation for innovation and excellence in drug development.

Collaborations

Hildenbrand has collaborated with esteemed colleagues such as Peter Maienfisch and Jean-Claude Gehret. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceuticals.

Conclusion

Christor Hildenbrand's contributions to anthelmintics highlight his role as an innovator in the pharmaceutical industry. His patent and collaborations reflect a commitment to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…